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Background: Photoimmunotherapy (PIT) is a highly cell-selective cancer therapy, which employs monoclonal
antibodies conjugated to a potent photosensitizer (mAb-IR700). Once the conjugate has bound to the target cell,
exposure to near infrared (NIR) light induces necrosis only in targeted cells with minimal damage to adjacent
normal cells in vivo. Herein, we report on the effect of altering mAb-IR700 and light power and dose on
effectiveness of PIT.
Methods: For evaluating cytotoxicity, we employed ATP-dependent bioluminescence imaging using a
luciferase-transfected MDA-MB-468luc cell line, which expresses EGFR and luciferase. In in vitro experiments,
panitumumab-IR700 (Pan-IR700) concentration was varied in combination with varying NIR light doses administered by
an LED at one of three power settings, 100 mA and 400 mA continuous wave and 1733 mA intermittent wave. For
in vivo experiments, the MDA-MB-468luc orthotopic breast cancer was treated with varying doses of Pan-IR700 and
light.
Results: The in vitro cell study demonstrated that PIT induced cytotoxicity depended on light dose, when the
conjugate concentration was kept constant. Increasing the dose of Pan-IR700 allowed lowering of the light dose to
achieve equal effects thus indicating that for a given level of efficacy, the conjugate concentration multiplied by the
light dose was a constant. A similar relationship between conjugate and light dose was observed in vivo.
Conclusions: The efficacy of PIT is defined by the product of the number of bound antibody conjugates and the dose
of NIR light and can be achieve equally with continuous and pulse wave LED light using different power densities.
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Photoimmunotherapy (PIT) is a highly cell-selective can-
cer therapy, which utilizes a monoclonal antibody (mAb)
conjugated to the photosensitizing phthalocyanine dye,
IRDye700DX (IR700). After intravenous injection, mAb-
IR700 conjugates preferentially to cancer cells expressing
the proper antigen and subsequent exposure of the cells
to near infrared (NIR) light induces highly selective and
rapid cell necrosis. An attractive feature of PIT is that
minimal damage is seen in adjacent normal cells [1].
The effectiveness of PIT appears generalizable across a
number of different types of cancers and with multiple* Correspondence: Kobayash@mail.nih.gov
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unless otherwise stated.mAb-IR700 conjugates [2]. When the mAb-IR700 conju-
gate is well matched to the target tumor, exposure to
NIR light results in rapid and severe damage to the cell
membrane inducing necrotic cell death within a minute
[3]. However, the relationship between the dose of mAb-
IR700 and the dose or power density of NIR light has
not been fully investigated. Optimized dosing of NIR
light exposure is critical for planning a successful clinical
trial of PIT in both therapeutic efficacy and patient
safety.
PIT induces cell death by necrosis that releases ATP
from cells, which is quickly hydrolyzed. Thus, we em-
ployed ATP-dependent bioluminescence imaging of firefly
luciferase transfected cells as a readout of the effectiveness
of PIT while varying the dose of the mAb-IR700 and NIR
light that was proven to be a more accurate biomarker foral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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within 3 days after PIT [4,5].
Methods
Reagents
Panitumumab, a fully humanized IgG2 monoclonal anti-
body (mAb) directed against human EGFR was purchased
from AMGEN Inc. (Thousand Oaks, CA). A water sol-
uble,silicon-based-phthalocyanine dye derivative, IRDye
700DX NHS ester (IR700; C74H96N12Na4O27S6Si3, molecu-
lar weight of 1954.22), was obtained from LI-COR
Bioscience (Lincoln, NE). All other chemicals used were of
reagent grade.
Synthesis of IR700-conjugated Panitumumab
Panitumumab (1 mg, 6.8 nmol) was incubated with IR700
(66.8 μg, 34.2 nmol, 5 mmol/L in DMSO) in 0.1 mol/L
Na2HPO4 (pH 8.5) at room temperature for 1 h. Then
the mixture was purified with a Sephadex G50 column
(PD-10; GE Healthcare, Piscataway, NJ). The protein con-
centration was determined with a Coomassie Plus protein
assay kit (Pierce Biotechnology, Rockford, IL) by mea-
suring the absorption at 595 nm (8453 Value System;
Agilent Technologies, Santa Clara, CA). The concentra-
tion of IR700 was measured by its absorption to confirm
the number of fluorophore molecules conjugated to each
Panitumumab molecule. The number of IR700 per anti-
body was approximately 4 for the 1:4.5 reaction con-
ditions. The resulting compound, Pan-IR700, was kept at
4°C as a stock solution.
Cell line
EGFR-expressing MDA-MB-468luc, [6] stable luciferase-
transfected cells were grown in RPMI 1640 supple-
mented with 10% fetal bovine serum and 1% penicillin/
streptomycin in tissue culture flasks using a humidified
incubator at 37°C in an atmosphere of 95% air and 5%
carbon dioxide.
Fluorescence microscopy
To detect the antigen specific localization of Pan-IR700,
fluorescence microscopy was performed (BX61; Olympus
America, Melville, NY). MDA-MB-468luc was seeded on
cover-glass-bottomed dishes and incubated for 16 h.
Pan-IR700 conjugate (10 μg/mL) was added to the culture
medium and incubated for 6 h at 37°C, followed by
washing with PBS. The filter was set to detect IR700
fluorescence with a 590–650 nm excitation filter and a
665–740 nm band pass emission filter.
Phototoxicity assay
Cytotoxicity of PIT was determined by measuring luci-
ferase activity and by quantitative flow cytometry using
propidium iodide (PI) as a stain for dead cells. For theluciferase activity assay, d-luciferin (150 μg/ml, Gold
Biotechnology, St. Louis, MO) was added to the culture
medium and bioluminescence (signal intensity) was de-
tected (Photon Imager; Biospace Lab, Cambridge, MA).
For the flow cytometry assay, cells were trypsinized after
treatment, washed with PBS and 1 μL of PI (5 mg/mL)
was added to the cell suspension which was vortexed.
Cells were analyzed on a flow cytometer (FACS Calibur;
BD BioSciences, San Jose, CA).In vitro photoimmunotherapy
Cells were seeded on a 96 well plate or 35 mm cell culture
dishes and incubated for 8 h at 37°C. The culture medium
was refreshed and 10 μg/mL of Pan-IR700 was added over
night. After washing with PBS, phenol red free culture
medium was added. Then, cells were irradiated with a red
light-emitting diode (LED), which emits light at 670 to
710 nm wavelength (L690-66-60; Marubeni America Co.,
New York, NY), controlled by FluorVivo software (INDEC
Systems, Santa Clara, CA) at a current of 100 mA (con-
tinuous-wave; CW), 400 mA (CW) and 1733 mA (pulse-
wave; PW). The pulse wave duration was 0.2 ms separated
by 0.8 ms so that the pulse occurred every 1 ms (Figure 1).
The power density of the LED was 12.5 mW/cm2 at
100 mA CW and 25 mW/cm2 at 400 mA CW and
1733 mA PW as measured with an optical power meter
(PM 100; Thorlabs, Newton, NJ).
MDA-MB-468luc cells were irradiated at 0.2, 0.5, 2 and
5 J/cm2 using all 3 power settings (100 mA CW, 400 mA
CW and 1733 mA PW). Cell viability was analyzed with
flow cytometry and bioluminescence imaging.
Pan-IR700 was added to cells at concentrations of 0.3, 1,
3, 10 μg/mL. Cells were incubated for 8 h followed by
washing once with PBS and restoration of phenol red free
culture medium. The cells were then irradiated with the
LED light of 400 mA (CW) at a total dose of 2 J/cm2.
In vitro treatments for cells were performed using the
following combinations of Pan-IR700 and NIR light dose:
(1) 3 μg/mL and 0.5 J/cm2, (2) 1 μg/mL and 1.5 J/cm2,
and (3) 0.3 μg/mL and 5 J/cm2.Tumor model
All procedures were carried out in compliance with the
Guide for the Care and Use of Laboratory Animal Re-
sources (1996), National Research Council, and approved
by the local Animal Care and Use Committee. Six- to eight-
week-old female homozygote athymic nude mice were pur-
chased from Charles River (NCI-Frederick, Frederick, MD).
During the procedure, mice were anesthetized with isoflur-
ane. MDA-MB-468luc cells (2 × 106 cells) were injected
subcutaneously into the right mammary pads of the mice.
The experiments were conducted 2 weeks after MDA-MB-
468luc cell implantation.
Figure 1 Schematic sequences of LED irradiation. (A) Pulse wave (PW) lighting is achieved via peak currents of 1733 mA. (B) Continuous
wave (CW) lighting at 400 mA and 100 mA. (C) The irradiation times were 20 min for the 1733 mA (PW) and 400 mA (CW) and it took 40 min for
irradiation at 100 mA (CW). Total irradiation dose of these three groups was adjusted to 30 J/cm2. (D) Photograph of LED lights, left; 1733 mA
(PW), right; 400 mA (CW).
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of LED light
Orthotopic breast tumors were irradiated at all three
power settings, 100 mA (CW), 400 mA (CW) and
1733 mA (PW). Total irradiation doses were 30 J/cm2 with
power density of 200 mW/cm2. Mice images were ac-
quired with a fluorescence imager (Pearl Imager; LI-COR
Biosciences) for detecting IR700 fluorescence, and Photon
Imager for BLI. BLI was used for evaluation of PIT effects.
Regions of interest (ROIs) were placed over the entire
tumor and photon numbers were counted for each ROI.Statistical analysis
Statistical analysis was performed using a statistics pro-
gram (GraphPad Prism6, GraphPad Software, La Jolla,
CA). A one-way analysis of variance (ANOVA) was used
to compare differences in responses to level of light expo-
sure among the three groups. Pearson’s correlation coef-
ficient was used to analyze the correlation between the
dead cell ratio and the concentrations of Pan-IR700.
Values of p < 0.05 were considered statistically significant.Results
Target specific binding of Pan-IR700 to EGFR on
fluorescence microscopy
Fluorescence microscopy was performed to confirm
target-specific localization of Pan-IR700. Fluorescence
was mainly localized to the cell membrane and lysosomes
of the cells. During continuous NIR light exposure the
cells demonstrated almost immediate swelling, buddingand rupture of the membrane was observed leading to
irreversible cell death (Figure 2).
Effect of phototoxicity in response to Pan-IR700 mediated
PIT
Flow cytometry showed that the ratio of dead cells in-
creased from ~40 to ~85% as the light dose increased
from 0.2 to 5 J/cm2 at every LED light power; 100, 400
and 1733 mA. At each light dose, no significant difference
was observed in rate of cell death was seen among the
3 power levels (Figure 3A, 0.2 J/cm2: p > 0.05, 0.5 J/cm2:
p > 0.05, 2 J/cm2: p > 0.05, 5 J/cm2: p = 0.014). Low levels
of LED light irradiation dose (0.2 J/cm2) demonstrated
relatively high bioluminescence signals. Bioluminescence
signals decreased as exposure to NIR light dose increased.
Bioluminescence signals were similar among the 3 dif-
ferent power levels at the same light dose (see Figure 3B,
0.2 J/cm2: p > 0.05, 0.5 J/cm2: p > 0.05, 2 J/cm2: p > 0.05,
5 J/cm2: p = 0.036). Larger doses of NIR light (5 J/cm2) re-
sulted in correspondingly lower bioluminescence signals.
Correlation between the concentration of Pan-IR700 and
the irradiation dose
A positive monoexponential correlation was seen be-
tween concentrations of Pan-IR700 ranging from 0.3 to
3 μg/mL and the cell death rate at a constant NIR light
dose of 2 J/cm2 (Figure 4A, R2 = 0.94). Next we defined
the effective dose parameter (1.5 J・μg/mL・cm2) by
multiplying the Pan-IR700 concentration by the light
dose. The cell death rate of the following combinations:
(1) 3 μg/mL and 0.5 J/cm2, (2) 1 μg/mL and 1.5 J/cm2,
Figure 2 Sequential microscopic images of MDA-MB-468luc cells treated with Pan- IR700 (images before (left), during (middle) and after
(right) irradiation, upper images; DIC images, lower images; fluorescence images). PIT induced cell death with swelling, budding and rupture
of the membrane as shown on the DIC images (middle and right). Fluorescence signals decreased after continuous NIR irradiation. Scale bar:
50 μm (original magnification, ×400).
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ference (Figure 4B, p > 0.05). The correlation between the
light dose and the concentration of Pan-IR700 fit the fol-
lowing equation: [concentration of Pan-IR700 (μg/mL)] =
9.65e^-1.15 [irradiation dose (J/cm2)] (Figure 4C).Figure 3 Effect of phototoxicity in response to Pan-IR700 mediated P
staining using PI and (B) bioluminescence after LED light irradiation in MDIn vivo photoimmunotherapy assessed by
bioluminescence imaging
All NIR light exposure of 30 J/cm2 with three different
light power levels (100 mA CW, 400 mA CW and
1733 mA PW) induced decreased bioluminescence signalsIT. Cell viability was analyzed with (A) flow cytometory with dead
A-MB-468luc cells. (n = 3, n.s. p > 0.05, *p < 0.05).
Figure 4 Correlation between the concentration of Pan-IR700 and light dose for cell killing. (A) At as constant light dose of 2 J/cm2, as
the concentration of Pan-IR700 increased from 0.3 to 3 μg/mL, the percentage of dead cells increased. There was a positive linear correlation on
a log scale between increasing dose and cell killing at a constant light dose (R2 = 0.94). Note, that above 3 μg/mL no further increases in cell
death are seen due to saturation of the membrane antigens. (B) The same rate of cell killing (measured by bioluminescence imaging) could be
achieved by any of the following combinations: (1) 3 μg/mL and 0.5 J/cm2, (2) 1 μg/mL and 1.5 J/cm2, and (3) 0.3 μg/mL and 5 J/cm2) resulting
in no significant difference among these three groups (p > 0.05). (C) The correlation between light dose and the concentration of Pan-IR700
derived the following equation: [concentration of Pan-IR700] = 9.65e^-1.15 [irradiation dose]. The product of the light dose (in J/cm2) and the
concentration of Pan-IR700 (in μg/mL) is a constant of 1.5.
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tumor. Bioluminescent photon counts of all these three
groups decreased 61.4%; 100 mA (CW) 61% (400 mA
(CW), 61.5%; 1733 mA (PW), 61.4%) 1 day after NIR light
exposure (Figure 5).
Discussion
These data demonstrate that increased cytotoxicity with
PIT can be achieved by either increasing the dose of the
mAb-IR700 (up to the saturating dose) or increasing the
dose of light (up to the thermal limits). Moreover, a con-
stant level of cell killing can be achieved by modulating
the doses of both the conjugate and the light dose.Figure 5 In vivo photoimmunotherapy in orthotopic breast tumors w
400 mA (CW) and 1733 mA (PW) LED light. (A) Photon counts on biolu
Photon counts of tumors in these three groups decreased around 60% (40
after LED irradiation. (B) In vivo fluorescence (upper row) and bioluminesce
after Pan-IR700 mediated PIT.These data also demonstrate that the power density
(mW/cm2) of the light source is not as critical a factor
as is the light dose (J/cm2) in determining the effective-
ness of PIT. Moreover, the effect of a given light dose is
independent of the manner in which the light is deli-
vered, that is, either continuously or intermittently. Only
at the relatively high light dose of 5 J/cm2, was a signifi-
cant difference seen in dead staining and biolumines-
cence, among three power settings probably due to the
long exposure times required to reach such a high light
dose with low power NIR light (100 mA).
In addition to the effect of light dose, these data confirm
that increasing concentrations of Pan-IR700 induced moreith a constant dose of 30 J/cm2 delivered by 100 mA (CW),
minescence images of tumors before and 1 day after LED irradiation.
0 mA (CW), 60.1%; 100 mA (CW), 60.1%; 1733 mA (PW), 60.1%) 1 day
nce imaging (lower row) of orthotopic breast tumors before and 1 day
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ever, above a concentration of 3 μg/mL of Pan-IR700 no
further increases in cell death were seen suggesting that the
EGFR antigens on the MDA-MB-468luc cell surface were
saturated with Pan-IR700 at 3 μg/mL and therefore, higher
doses did not result in further effectiveness (Figure 4).
MDA-MB-468 orthotopic breast tumors in mice admi-
nistered Pan-IR700 showed ~60% decrease of biolumines-
cence signals after 30 J/cm2 of NIR light exposure. In vivo
cytotoxicity data confirmed in vitro data that PIT-induced
cytotoxicity is related to the product of the dose of the
conjugate (up to the saturating dose) and the light dose.
In order to decrease either the dose of the conjugate or
the light dose and achieve similar results, the spectral pro-
file of the light source would need to be improved. In this
study, we used an LED which emitted 690 ± 20 nm of NIR
light. However, the absorbance spectrum of IR700 around
690 nm is sharper than the emission spectrum of this LED.
Therefore, a large proportion of the exposed energy was
not absorbed by IR700. Theoretically, we could improve
the quantum efficiency of the light dose by using a laser
light source tuned to emit a single 690 nm wavelength of
light (± 5 nm).
Fluorescent proteins (FPs) are an excellent method for
monitoring preclinical tumor growth in vivo [7-10]. FPs are
stable and therefore ideal for longitudinal monitoring of
photo-induced cancer therapies as has been shown previ-
ously [11,12]. However, FPs keep glowing before they are
taken up and catabolized by macrophages in vivo [13] that
takes hours after cell death [7]. In the current application
the rapidity, with which PIT induces cell death, is difficult
to detect with FPs as fluorescence would persist after cell
death especially in vitro. Because firefly luciferin-based bio-
luminescence is an ATP-dependent process and ATP is
released from damaged cells and hydrolyzed during or
shortly after PIT, bioluminescence imaging is theoretically
and practically an appropriate method for detecting in vivo
PIT-induced cell necrosis [4]. Furthermore, FPs are ex-
cellent endogenous fluorescence emitters and/or singlet
oxygen producers for operating as photo-dynamic therapy
(PDT) agents. For selectively targeting cancer, recently
reported technology is the use of telomerase promoter-
regulated expression of various fluorescent proteins, which
are induced with adenovirus-mediated gene transfection
in vivo [11,12,14,15]. However, the requirement for virus-
mediated in vivo gene transfection makes it unlikely to be
translated for human use in the near term. In contrast, the
PIT technology described here should be readily translat-
able as it requires the injection of an antibody-IR700 conju-
gate and exposure to non-thermal levels of NIR light.
Conclusion
We demonstrate that cell killing with PIT is dependent
on conjugate dose, up to the saturating dose, and thelight dose. We found that a constant level of cell death
could be achieved by varying the conjugate dose and
light dose in such a way that the product was a constant.
At a defined conjugate-light dose product, the cytotoxic
effect of PIT is the same regardless of how the light is
delivered (continuously or intermittently). This result
suggests that the cytotoxic effect induced by PIT, which
depends on the number of bound mAb-IR700 molecules
and the exposed light dose, is highly predictable. Since
the number of bound mAb-IR700 conjugates is roughly
proportional to the intensity of IR700 fluorescence, this
value could be used to calculate the appropriate effective
and safe light dose in the future.
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